ARTICLE | Clinical News
Dermagraft: Phase III started
February 18, 2013 8:00 AM UTC
Shire began an open-label, international Phase III trial to compare topical ABH001 applied every 4 weeks plus protocol-specified dressings vs. control wound care plus protocol-specified dressings for ...